Guat See Ooi
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Guat See Ooi has a total of 79 co-authors. Here are the top co-authors by number of shared publications:
- Mohamed Azmi Hassali
School of Pharmaceutical Sciences, Universiti Sains Malaysia, Penang 11800, Malaysia
5 shared publications - Asrul Akmal Shafie
School of Pharmaceutical Sciences, Universiti Sains Malaysia, Gelugor, Malaysia
4 shared publications - Siew Chin Ong
Universiti Sains Malaysia
3 shared publications - Yen Ping Ng
Faculty of Pharmacy Quest International University Perak Malaysia
3 shared publications Vivienne S. L. Mak
School of Pharmacy; Monash University Malaysia; Selangor Malaysia
2 shared publications- Abu Bakar
Discipline of Social and Administrative Pharmacy, School of Pharmaceutical Science, Universiti Sains Malaysia, 11800 Gelugor, Penang, Malaysia
1 shared publication
Latest Publications
- 7 August 2026
- Published by Wiley in Journal of Pharmacy Practice and Research
Mapping the evolution of pharmacist interventions in primary care: a bibliometric analysis (2015–2026)
Background: Since 2015, pharmacists have become increasingly involved in primary care and interdisciplinary healthcare teams. Subsequently, literature related to pharmacist interventions in primary care has grown rapidly and there is a need to systematically map this research to understand how the profession's clinical focus has evolved and conceptually matured. Aim: This study aimed to identify research concerning pharmacist interventions in primary health care, published from January 2015 to 26 January 2026, and use bibliometric mapping to identify core research themes and trends and assess the maturity of these themes. Method: A total of 691 relevant documents were retrieved using Scopus and analysed. Advanced bibliometric techniques were employed using VOSviewer, Biblioshiny, OpenRefine and biblioMagika software to conduct performance mapping and author keyword co‐occurrence analysis. Network, density and thematic maps were generated to visually demonstrate thematic maturity, topic saturation and the evolution of the research domains over time. Ethics approval was not required for this research article as it utilised published data and did not contain human participants or data. Results: Research output related to pharmacist interventions in primary care exhibited sustained, exponential growth, peaking in 2025. The core literature remained robustly anchored in community pharmacy settings. Co‐occurrence and thematic mapping identified five highly interconnected clusters. The key terms ‘comprehensive medication management’ and ‘patient‐centred care’ represented a rapidly emerging, rather than declining, research trajectory. Conclusion: The literature analysed reflected a mature, global transition towards proactive, multidisciplinary pharmacist‐led care. To further advance the pharmacy profession, future research must examine settings beyond community pharmacy to address critical gaps, such as specialised ambulatory care and psychosocial interventions, and ultimately optimising macro‐level population health outcomes.
- 7 August 2026
- Published by Wiley in Journal of Pharmacy Practice and Research
Mapping the evolution of pharmacist interventions in primary care: a bibliometric analysis (2015–2026)
Background: Since 2015, pharmacists have become increasingly involved in primary care and interdisciplinary healthcare teams. Subsequently, literature related to pharmacist interventions in primary care has grown rapidly and there is a need to systematically map this research to understand how the profession's clinical focus has evolved and conceptually matured. Aim: This study aimed to identify research concerning pharmacist interventions in primary health care, published from January 2015 to 26 January 2026, and use bibliometric mapping to identify core research themes and trends and assess the maturity of these themes. Method: A total of 691 relevant documents were retrieved using Scopus and analysed. Advanced bibliometric techniques were employed using VOSviewer, Biblioshiny, OpenRefine and biblioMagika software to conduct performance mapping and author keyword co‐occurrence analysis. Network, density and thematic maps were generated to visually demonstrate thematic maturity, topic saturation and the evolution of the research domains over time. Ethics approval was not required for this research article as it utilised published data and did not contain human participants or data. Results: Research output related to pharmacist interventions in primary care exhibited sustained, exponential growth, peaking in 2025. The core literature remained robustly anchored in community pharmacy settings. Co‐occurrence and thematic mapping identified five highly interconnected clusters. The key terms ‘comprehensive medication management’ and ‘patient‐centred care’ represented a rapidly emerging, rather than declining, research trajectory. Conclusion: The literature analysed reflected a mature, global transition towards proactive, multidisciplinary pharmacist‐led care. To further advance the pharmacy profession, future research must examine settings beyond community pharmacy to address critical gaps, such as specialised ambulatory care and psychosocial interventions, and ultimately optimising macro‐level population health outcomes.
- 16 August 2024
- Published by Oxford University Press (OUP) in Journal of Pharmaceutical Health Services Research
- Vol. 15 (3)
Physicians’ opinions on the utilization of generic medications in Gulf Cooperation Council countries: a narrative review
This review paper explores strategies and recommendations for reducing healthcare expenses in the Gulf Cooperation Council (GCC) by understanding physicians’ attitudes regarding the utilization of generic medicines. A comprehensive search of seven databases yielded 24 437 titles and abstracts. Using inclusion criteria focusing on physicians’ insights into generic prescribing and exclusion criteria, cutting out systematic reviews, case studies, and non-English articles, the review process led to an in-depth analysis of six studies. Findings revealed that while physicians generally comprehend terms like “generic”, “brand”, and “bioequivalence”, they face difficulty discussing bioequivalence with patients. Lack of emphasis on generic medicines in medical education and complex patient communication were potential impediments to generic medicine prescribing in the GCC countries. Strategies & Recommendations: Promoting the benefits of generic drugs could support their usage and help decrease healthcare costs. Improving medical education to include a larger focus on generic medications and their benefits, as well as training physicians in effectively communicating bioequivalence concepts to patients, could promote the use of more cost-effective, generic options. The review calls for attention to the potential of generic medicine prescribing to reduce healthcare expenses in the GCC. Future research studies should consider broadening the geographical scope to provide global insights into these issues and their possible solutions.
- 16 August 2024
- Published by Oxford University Press (OUP) in Journal of Pharmaceutical Health Services Research
- Vol. 15 (3)
Physicians’ opinions on the utilization of generic medications in Gulf Cooperation Council countries: a narrative review
This review paper explores strategies and recommendations for reducing healthcare expenses in the Gulf Cooperation Council (GCC) by understanding physicians’ attitudes regarding the utilization of generic medicines. A comprehensive search of seven databases yielded 24 437 titles and abstracts. Using inclusion criteria focusing on physicians’ insights into generic prescribing and exclusion criteria, cutting out systematic reviews, case studies, and non-English articles, the review process led to an in-depth analysis of six studies. Findings revealed that while physicians generally comprehend terms like “generic”, “brand”, and “bioequivalence”, they face difficulty discussing bioequivalence with patients. Lack of emphasis on generic medicines in medical education and complex patient communication were potential impediments to generic medicine prescribing in the GCC countries. Strategies & Recommendations: Promoting the benefits of generic drugs could support their usage and help decrease healthcare costs. Improving medical education to include a larger focus on generic medications and their benefits, as well as training physicians in effectively communicating bioequivalence concepts to patients, could promote the use of more cost-effective, generic options. The review calls for attention to the potential of generic medicine prescribing to reduce healthcare expenses in the GCC. Future research studies should consider broadening the geographical scope to provide global insights into these issues and their possible solutions.
- Open Access
- 31 December 2023
- Published by Taylor & Francis in Journal of Pharmaceutical Policy and Practice
- Vol. 16 (1) , 1-15
Risk-taking in consumers’ online purchases of health supplements and natural products: a grounded theory approach
Health supplements and natural products are widely used by the general public to support physical function and prevent disease. Additionally, with the advent of e-commerce, these products have become easily accessible to the general public. Although several theoretical models have been used to explain the use of health supplements and natural products, empirical evidence on how consumers make decisions to purchase online health supplements and natural products remains limited. In this study, a grounded theory approach was used to develop a substantive theoretical model with the aim of investigating the decision-making process of consumers when purchasing health supplements and natural products online. Malaysian adult consumers who had purchased these products via the Internet were either purposively or theoretically sampled. A total of 18 virtual in-depth interviews (IDIs) were conducted to elicit participants’ experiences and priorities in relation to this activity. All the IDIs were audio-recorded and transcribed verbatim. The data were analysed using open coding, focus coding and theoretical coding. The analytical interpretations and theoretical concepts were recorded in research memos. Consumers’ decisions to purchase a health supplement or natural product over the Internet are based on a series of assessments regarding the perceived benefits and risks of this activity, which may be related to the product or the process. In the online marketplace, consumers attempt to choose products, online sellers, sales platforms and/or purchase mechanisms with lower perceived risk, which ultimately enhances their confidence in five elements related to the purchase: (1) product effectiveness, (2) product safety, (3) purchase convenience, (4) fair purchase and (5) online security. Consumers take an acceptable level of risk to purchase these products online, and this acceptable level is unique to each individual and is based on their perception of having control over the potential consequences if the worst-case scenario occurs. In this study, a substantive theoretical model is developed to demonstrate how consumers decide to purchase online health supplements and natural products by accepting an acceptable level of risk associated with the product or process. The emerging model is potentially transferable to other populations in similar contexts.
- 31 December 2023
- Published by Taylor & Francis in Journal of Pharmaceutical Policy and Practice
- Vol. 16 (1) , 1-15
Open AccessRisk-taking in consumers’ online purchases of health supplements and natural products: a grounded theory approach
Health supplements and natural products are widely used by the general public to support physical function and prevent disease. Additionally, with the advent of e-commerce, these products have become easily accessible to the general public. Although several theoretical models have been used to explain the use of health supplements and natural products, empirical evidence on how consumers make decisions to purchase online health supplements and natural products remains limited. In this study, a grounded theory approach was used to develop a substantive theoretical model with the aim of investigating the decision-making process of consumers when purchasing health supplements and natural products online. Malaysian adult consumers who had purchased these products via the Internet were either purposively or theoretically sampled. A total of 18 virtual in-depth interviews (IDIs) were conducted to elicit participants’ experiences and priorities in relation to this activity. All the IDIs were audio-recorded and transcribed verbatim. The data were analysed using open coding, focus coding and theoretical coding. The analytical interpretations and theoretical concepts were recorded in research memos. Consumers’ decisions to purchase a health supplement or natural product over the Internet are based on a series of assessments regarding the perceived benefits and risks of this activity, which may be related to the product or the process. In the online marketplace, consumers attempt to choose products, online sellers, sales platforms and/or purchase mechanisms with lower perceived risk, which ultimately enhances their confidence in five elements related to the purchase: (1) product effectiveness, (2) product safety, (3) purchase convenience, (4) fair purchase and (5) online security. Consumers take an acceptable level of risk to purchase these products online, and this acceptable level is unique to each individual and is based on their perception of having control over the potential consequences if the worst-case scenario occurs. In this study, a substantive theoretical model is developed to demonstrate how consumers decide to purchase online health supplements and natural products by accepting an acceptable level of risk associated with the product or process. The emerging model is potentially transferable to other populations in similar contexts.
- 15 June 2023
- Published by Elsevier in Journal of the American Pharmacists Association
- Vol. 63 (5) , 1634-1642.e3
Implementing a chatbot on Facebook to reach and collect data from thousands of health care providers: PharmindBot as a case
- 15 June 2023
- Published by Elsevier in Journal of the American Pharmacists Association
- Vol. 63 (5) , 1634-1642.e3
Implementing a chatbot on Facebook to reach and collect data from thousands of health care providers: PharmindBot as a case
- Open Access
- 23 February 2022
- Published by Universiti Putra Malaysia in Pertanika Journal of Social Sciences and Humanities
- Vol. 30 (1) , 41-56
Barriers for Implementation of E-pharmacy Policy: Views of Pharmacy Authorities, Public Institutions and Societal Groups
Malaysian government has established National Digital Economy Policy to promote e-commerce adoption among small to medium enterprises (SMEs). Although this national policy has expanded to community pharmacists for providing e-pharmacy services, only a few independent pharmacies have adopted e-pharmacy practices. As such, it is important to critically investigate the implementation of e-pharmacy policies in promoting online pharmaceutical services in Malaysia. This study explores the barriers in implementing e-pharmacy policies from the perspective of pharmaceutical authorities, public agencies and societal groups. The Consolidated Criteria for Reporting Qualitative Research (COREQ) was employed in this study. Interview data were collected from key pharmaceutical authorities, agencies governing e-commerce and consumer affairs, health professionals and consumer societal groups. Thirty-three key actors participated in this study. Themes focusing on factors that impede the implementation of e-pharmacy policies were identified using an open-axial coding approach. Eight emerging themes were identified to be influencing policy inaction and policy barriers towards e-pharmacy implementation for empowering community pharmacists: (1) policymakers’ inattention to private business interests; (2) authoritarian administrative action unsuitable for e-pharmacy businesses; (3) deficit of trust towards community pharmacies practising e-pharmacy services; (4) conflicting policy requirements between safeguarding patients and business applications; (5) limited organisational resources and budget constraints; (6) policy incompatibility and different jurisdiction requirements; (7) unfriendly e-pharmacy requirements; and (8) dominant interest groups opposing e-pharmacy policies. Clear and consistent policies will benefit both patients and consumers as they acquire improved access to professional consultation and various options for quality medicine at competitive prices.
- 23 February 2022
- Published by Universiti Putra Malaysia in Pertanika Journal of Social Sciences and Humanities
- Vol. 30 (1) , 41-56
Open AccessBarriers for Implementation of E-pharmacy Policy: Views of Pharmacy Authorities, Public Institutions and Societal Groups
Malaysian government has established National Digital Economy Policy to promote e-commerce adoption among small to medium enterprises (SMEs). Although this national policy has expanded to community pharmacists for providing e-pharmacy services, only a few independent pharmacies have adopted e-pharmacy practices. As such, it is important to critically investigate the implementation of e-pharmacy policies in promoting online pharmaceutical services in Malaysia. This study explores the barriers in implementing e-pharmacy policies from the perspective of pharmaceutical authorities, public agencies and societal groups. The Consolidated Criteria for Reporting Qualitative Research (COREQ) was employed in this study. Interview data were collected from key pharmaceutical authorities, agencies governing e-commerce and consumer affairs, health professionals and consumer societal groups. Thirty-three key actors participated in this study. Themes focusing on factors that impede the implementation of e-pharmacy policies were identified using an open-axial coding approach. Eight emerging themes were identified to be influencing policy inaction and policy barriers towards e-pharmacy implementation for empowering community pharmacists: (1) policymakers’ inattention to private business interests; (2) authoritarian administrative action unsuitable for e-pharmacy businesses; (3) deficit of trust towards community pharmacies practising e-pharmacy services; (4) conflicting policy requirements between safeguarding patients and business applications; (5) limited organisational resources and budget constraints; (6) policy incompatibility and different jurisdiction requirements; (7) unfriendly e-pharmacy requirements; and (8) dominant interest groups opposing e-pharmacy policies. Clear and consistent policies will benefit both patients and consumers as they acquire improved access to professional consultation and various options for quality medicine at competitive prices.
- 31 December 2021
- Published by Malaysian Pharmacists Society in Malaysian Journal of Pharmacy
- Vol. 7 (2) , 1-2
professor-dr-mohamed-azmi-bin-ahmad-hassali-1974-2021
The profession of pharmacy had lost one of its key intellectual leaders when Prof. Dr. Mohamed Azmi Ahmad Hassali (Fig.1) had suddenly passed away on 16th of July, 2021.
- 31 December 2021
- Published by Malaysian Pharmacists Society in Malaysian Journal of Pharmacy
- Vol. 7 (2) , 1-2
professor-dr-mohamed-azmi-bin-ahmad-hassali-1974-2021
The profession of pharmacy had lost one of its key intellectual leaders when Prof. Dr. Mohamed Azmi Ahmad Hassali (Fig.1) had suddenly passed away on 16th of July, 2021.
- Open Access
- 31 July 2021
- Published by JCFCorp SG PTE LTD in Pharmacy Practice
- Vol. 19 (3) , 2469
Measuring the proportion of time spent on work activities of clinical pharmacists using work sampling technique at a public hospital in Malaysia
Background: The clinical pharmacy service to the ward was established in 2005 in Malaysia, as the number of pharmacists working in the public service sector began to grow. Yet, there has been little local research done on reporting the range of work activities of clinical pharmacists and the amount of time that they spent on their work activities. Objective: This study aimed to identify the range of work activities of clinical pharmacists by observation and to estimate the proportion of time spent on different work activities by using the work sampling technique. Methods: The time spent by clinical pharmacists on various activities was measured using the work sampling technique over 30 working days. The work activities of clinical pharmacists were pre-identified and customized into an activity checklist. Two observers were placed at the study site and took turns recording the activities performed by the clinical pharmacists by following a randomly generated observation schedule. Results: 1,455 observations were made on five clinical pharmacists with a total of 3493 events recorded. Overall, clinical pharmacists spent 78.8% (n=2751) of their time providing clinical services whereas 12.3% (n=433) of their time was spent on non-clinical activities. They were found to be idle from work for 8.9% of the time. There was no difference in bed occupancy rate in the study site regardless of the presence of the observer (p=0.384). Clinical pharmacists were found to report a higher average daily cumulative work unit of 9.8 (SD=4.3) when under observation compared to an average daily cumulative work unit of 6.5 (SD=4.6) when no observer was present (p=0.005). Conclusions: The results revealed that clinical pharmacists spent a significant amount of time on non-clinical work. Their responsibilities with non-clinical work should be properly taken care of so they can allocate more time to providing patient care.
- 31 July 2021
- Published by JCFCorp SG PTE LTD in Pharmacy Practice
- Vol. 19 (3) , 2469
Open AccessMeasuring the proportion of time spent on work activities of clinical pharmacists using work sampling technique at a public hospital in Malaysia
Background: The clinical pharmacy service to the ward was established in 2005 in Malaysia, as the number of pharmacists working in the public service sector began to grow. Yet, there has been little local research done on reporting the range of work activities of clinical pharmacists and the amount of time that they spent on their work activities. Objective: This study aimed to identify the range of work activities of clinical pharmacists by observation and to estimate the proportion of time spent on different work activities by using the work sampling technique. Methods: The time spent by clinical pharmacists on various activities was measured using the work sampling technique over 30 working days. The work activities of clinical pharmacists were pre-identified and customized into an activity checklist. Two observers were placed at the study site and took turns recording the activities performed by the clinical pharmacists by following a randomly generated observation schedule. Results: 1,455 observations were made on five clinical pharmacists with a total of 3493 events recorded. Overall, clinical pharmacists spent 78.8% (n=2751) of their time providing clinical services whereas 12.3% (n=433) of their time was spent on non-clinical activities. They were found to be idle from work for 8.9% of the time. There was no difference in bed occupancy rate in the study site regardless of the presence of the observer (p=0.384). Clinical pharmacists were found to report a higher average daily cumulative work unit of 9.8 (SD=4.3) when under observation compared to an average daily cumulative work unit of 6.5 (SD=4.6) when no observer was present (p=0.005). Conclusions: The results revealed that clinical pharmacists spent a significant amount of time on non-clinical work. Their responsibilities with non-clinical work should be properly taken care of so they can allocate more time to providing patient care.
- 24 July 2021
- Published by Oxford University Press (OUP) in International Journal of Pharmacy Practice
- Vol. 29 (5) , 515-520
Determinants of the choice of provisionally registered pharmacist (PRP) training in Malaysia: a qualitative insight
Objective: In Malaysia, due to provisional registered pharmacist (PRP) training places in government hospitals being oversubscribed, pharmacy graduates wait for about a year before starting their training. Therefore, a policy was implemented to allow pharmacy graduates to select their preferred areas of PRP training. This study was conducted to explore the perception and preferences of final year pharmacy students on the current PRP training system. Methods: This qualitative interview study was conducted among final year pharmacy students. Participants were recruited using convenience sampling until data saturation (i.e., when additional interviews didn’t lead to any new themes). All interviews were audio-recorded, transcribed verbatim, and evaluated by thematic analysis. Key findings: Twenty-two final year pharmacy students were interviewed. Fifteen of them preferred the government sector as their choice training, three chose the community sector, two preferred private hospitals and another two preferred the pharmaceutical industry. The majority of the students gave positive feedback towards the liberalization of PRP training sites. Most of them chose clinical pharmacy as their preferred training site despite knowing of the saturation issue in government hospitals. This was mainly due to the opportunity to gain clinical experience and knowledge from the government sector. A small number of students preferred the pharmaceutical industry based on their personal interests and opportunities for career advancement. Conclusion: Pharmacy students generally chose their PRP training site based on personal interest, future career advancement and working environment. A better understanding of career pathways and opportunities in the pharmaceutical industry by the students is required.
- 24 July 2021
- Published by Oxford University Press (OUP) in International Journal of Pharmacy Practice
- Vol. 29 (5) , 515-520
Determinants of the choice of provisionally registered pharmacist (PRP) training in Malaysia: a qualitative insight
Objective: In Malaysia, due to provisional registered pharmacist (PRP) training places in government hospitals being oversubscribed, pharmacy graduates wait for about a year before starting their training. Therefore, a policy was implemented to allow pharmacy graduates to select their preferred areas of PRP training. This study was conducted to explore the perception and preferences of final year pharmacy students on the current PRP training system. Methods: This qualitative interview study was conducted among final year pharmacy students. Participants were recruited using convenience sampling until data saturation (i.e., when additional interviews didn’t lead to any new themes). All interviews were audio-recorded, transcribed verbatim, and evaluated by thematic analysis. Key findings: Twenty-two final year pharmacy students were interviewed. Fifteen of them preferred the government sector as their choice training, three chose the community sector, two preferred private hospitals and another two preferred the pharmaceutical industry. The majority of the students gave positive feedback towards the liberalization of PRP training sites. Most of them chose clinical pharmacy as their preferred training site despite knowing of the saturation issue in government hospitals. This was mainly due to the opportunity to gain clinical experience and knowledge from the government sector. A small number of students preferred the pharmaceutical industry based on their personal interests and opportunities for career advancement. Conclusion: Pharmacy students generally chose their PRP training site based on personal interest, future career advancement and working environment. A better understanding of career pathways and opportunities in the pharmaceutical industry by the students is required.
- 18 December 2019
- Published by Oxford University Press (OUP) in Journal of Pharmaceutical Health Services Research
- Vol. 11 (2) , 141-148
Knowledge, attitude and disposing practice of unused and expired medicines among the general public in Malaysia
- 18 December 2019
- Published by Oxford University Press (OUP) in Journal of Pharmaceutical Health Services Research
- Vol. 11 (2) , 141-148
Knowledge, attitude and disposing practice of unused and expired medicines among the general public in Malaysia
- 1 December 2019
- Vol. 74 (6) , 477-482
Comparison of the efficacy and level of adherence for morning versus evening versus before bedtime administration of simvastatin in hypercholesterolemic patients.
Simvastatin is usually taken in the evening due to the circadian rhythm of hepatic cholesterol biosynthesis. The degree of reduction of low-density lipoprotein cholesterol (LDL-C) and the level of adherence to different administration time remained unknown in the Malaysian population. This study aims to investigate the effect of simvastatin on the percentage changes of lipid profile and the level of adherence to when simvastatin was instructed to be taken at different timing. Nine primary care health clinics across Malaysia participated in this study. 147 statin-naive subjects were selected through convenient sampling and randomised into one of the three arms (after breakfast, after dinner or before bedtime). Differences on percentage reduction of LDL-C from baseline and level of adherence among the three groups at week-16 were compared. The main outcomes measured in this study were the percentage change of lipid parameters and the percentage of high-adherence (MMAS=8) at week-16. 59.2% of the patients were male. The mean age of the study population was 53.93± 10.85 years. Most of the patients were Malays (69.4%); followed by Indians (22.4%) and Chinese (8.2%). LDL-C decreased from 4.26 (Standard Deviation, SD1.01) to 2.36 (SD0.69)mmol/L at week-16 for patients taking simvastatin before bedtime; an absolute reduction of 44.95%.The differences of LDL-C percentage reduction between three arms were significantly different (p<0.001). The greatest LDL-C reduction was observed when simvastatin was taken before bedtime and revealed 56.2% patients with high-adherence at week-16. Simvastatin showed superior LDL-reduction and higher level of adherence when being instructed to be taken before bedtime.
- 1 December 2019
- Vol. 74 (6) , 477-482
Comparison of the efficacy and level of adherence for morning versus evening versus before bedtime administration of simvastatin in hypercholesterolemic patients.
Simvastatin is usually taken in the evening due to the circadian rhythm of hepatic cholesterol biosynthesis. The degree of reduction of low-density lipoprotein cholesterol (LDL-C) and the level of adherence to different administration time remained unknown in the Malaysian population. This study aims to investigate the effect of simvastatin on the percentage changes of lipid profile and the level of adherence to when simvastatin was instructed to be taken at different timing. Nine primary care health clinics across Malaysia participated in this study. 147 statin-naive subjects were selected through convenient sampling and randomised into one of the three arms (after breakfast, after dinner or before bedtime). Differences on percentage reduction of LDL-C from baseline and level of adherence among the three groups at week-16 were compared. The main outcomes measured in this study were the percentage change of lipid parameters and the percentage of high-adherence (MMAS=8) at week-16. 59.2% of the patients were male. The mean age of the study population was 53.93± 10.85 years. Most of the patients were Malays (69.4%); followed by Indians (22.4%) and Chinese (8.2%). LDL-C decreased from 4.26 (Standard Deviation, SD1.01) to 2.36 (SD0.69)mmol/L at week-16 for patients taking simvastatin before bedtime; an absolute reduction of 44.95%.The differences of LDL-C percentage reduction between three arms were significantly different (p<0.001). The greatest LDL-C reduction was observed when simvastatin was taken before bedtime and revealed 56.2% patients with high-adherence at week-16. Simvastatin showed superior LDL-reduction and higher level of adherence when being instructed to be taken before bedtime.